Background-Cases of QT prolongation, torsades de pointes, and sudden death have been reported with arsenic trioxide (As 2 O 3 ), a highly effective agent for acute promyelocytic leukemia. In this study, we evaluated the effects of As 2 O 3 on repolarizing cardiac ion currents. Methods and Results-In HERG-or KCNQ1ϩKCNE1-transfected CHO cells (nϭ32; total), As 2 O 3 caused concentrationdependent block of both I Kr and I Ks , with an IC 50 for tail current block of 0.14Ϯ0.01 mol/L for I Kr and 1.13Ϯ0.06 mol/L for I Ks . In contrast to other QT-prolonging drugs, As 2 O 3 also activated a time-independent current that additional experiments identified as I K-ATP . Conclusions-As 2 O 3 blocks both I Kr and I Ks at clinically relevant concentrations. On the other hand, it also activates I K-ATP , which maintains normal repolarization. We infer that variability in the extent of QT interval prolongation and onset of ventricular arrhythmias during arsenic therapy represents competing effects to block and activate multiple repolarizing potassium currents. (Circulation. 2004;109:26-29.)
A pproximately 20% to 30% of patients with acute promyelocytic leukemia (APL) relapse with current standard all-trans retinoic acid and anthracycline-based chemotherapy regimen. 1 In the mid-1990s, studies from China reported that arsenic trioxide (As 2 O 3 ) achieved complete remission in as many as 90% of patients with APL, 2,3 and additional trials have confirmed these results. 4, 5 However, treatment has also been associated with QT prolongation, torsades de pointes, and sudden death. 4,6 -8 Because most of the patients receiving As 2 O 3 have been exposed to cardiotoxic chemotherapy, cardiac dysfunction is thought to be universal before As 2 O 3 therapy begins. 6, 9 In addition, hypokalemia and hypomagnesemia are among the most common As 2 O 3 -related side effects. 1 Thus, it has been proposed that QT prolongation and ventricular arrhythmias associated with arsenic could be exacerbated by concurrent electrolyte disturbances or previous chemotherapy-induced cardiac damage. 4,6 -8 Recently, clinically relevant concentrations of As 2 O 3 (1 to 10 mol/L) have been reported to prolong the action potential duration in guinea pig papillary muscle. 9 In another study using rabbit hearts, polymorphic ventricular tachycardia was observed with As 2 O 3 30 mol/L. 10 In this study, we therefore investigated the effects of As 2 O 3 on cardiac repolarizing currents and identified an unexpectedly complex profile that may underlie variability in the arrhythmogenic potential of arsenic.
Methods
Experiments were performed in CHO cells transfected with 2 g (each) of HERG, KCNQ1ϩKCNE1, or Kir6.2ϩSUR2A cDNAs. Kir6.2 and SUR2A cDNAs were kindly provided by Dr Joseph Bryan, Baylor College of Medicine, Houston, Tex. Cells were transfected using FuGENE 6 (Roche Applied Science). Green fluorescent protein (GFP) was coexpressed to identify transfected cells. All whole cell currents were recorded at 22°C to 23°C. Cells were held at Ϫ80 mV and pulsed to Ϫ40 to ϩ60 mV for 1 second (HERG) or 5 seconds (KCNQ1ϩKCNE1), and tail currents were measured at Ϫ40 mV. The maximal tail current amplitudes were sampled after the capacitive transient in a 20-ms window. The composition of extracellular and internal pipette solutions for the HERG and KCNQ1ϩKCNE1 experiments were as described previously. 11 For the Kir6.2ϩSUR2A experiments, cells were held at 0 mV and pulsed to Ϫ100 to ϩ50 mV for 100 ms. The composition of solutions for these experiments was as described previously. 12 As 2 O 3 solutions of the extracellular buffer (30 nmol/L to 10 mol/L) were prepared daily. Glibenclamide and pinacidil solutions in DMSO were prepared daily. The same concentration of DMSO (0.1% vol/vol) was also present in baseline and washout buffer solutions. As 2 O 3 , glibenclamide, and pinacidil were obtained from Sigma.
Statistical Analysis
Data are presented as meanϮSEM. Concentration-dependent block of HERG or KCNQ1ϩKCNE1 tail current was tested by the Hotelling t 2 test. PϽ0.05 was considered statistically significant. Figure 1A shows currents elicited in a HERG-transfected cell under baseline conditions and after 20 minutes of As 2 O 3 100 nmol/L ( Figure 1B ). In this cell, As 2 O 3 100 nmol/L caused a 60% reduction of the tail current. Unexpectedly, how-ever, there was also an increase in time-independent outward current ( Figure 1B, arrow) . Figures 1C and 1D show currents elicited before and during As 2 O 3 1 mol/L. In this cell, As 2 O 3 1 mol/L caused a 92% reduction of the tail current and clear activation of this time-independent outward current ( Figure 1D ). Figure 1E shows concentration dependence of the effect on I Kr tail current, with an IC 50 of 0.14Ϯ0.01 mol/L. Figures 1F  through 1J show a similar concentration-dependent block of I Ks (assessed by reduction of tail currents) and, again, activation of a time-independent outward current. I Ks was Ϸ1 order of magnitude less sensitive to block, with an IC 50 of 1.13Ϯ0.06 mol/L. Nearly all drugs that cause QT prolongation and torsades de pointes block I Kr , and some (eg, quinidine and azimilide) also block I Ks , often with somewhat higher IC 50 values. 13, 14 However, activation of an outward current, as in Figure 1 , has not been reported previously. Because this effect may reflect activation of a current endogenous to CHO cells, we next step-studied cells transfected with GFP only. Figure 2A shows currents elicited in a GFP-transfected cell under baseline conditions, and Figure 2B shows currents elicited after 20 minutes of As 2 O 3 1 mol/L. This gating pattern is reminiscent of I K-ATP , and Figure 2C shows that the current was blocked by subsequent exposure to the I K-ATP blocker glibenclamide 10 mol/L. Figures 2D through 2F show near-identical behaviors with the I K-ATP activator pinacidil 10 mol/L ( Figure 2E ) and 10 minutes after the addition of glibenclamide 10 mol/L ( Figure 2F ). To additionally test the hypothesis that As 2 O 3 activates I K-ATP , we studied Kir6.2ϩSUR2A-transfected CHO cells. Figures 2G through 2I show results similar to those in Figures 2A through 2C , demonstrating activation of I K-ATP by As 2 O 3 1 mol/L. Figures 2J through 2L show that pinacidil 10 mol/L activates a similar current and glibenclamide 10 mol/L blocks this current, as expected.
Results

Discussion
Our results show that As 2 O 3 is a potent blocker of I Kr (IC 50 , 0.14Ϯ0.01 mol/L) and I Ks (IC 50 , 1.13Ϯ0.06 mol/L). It has been shown that I Kr block may lead to triggered tachyarrhythmias and sudden death. 15 Moreover, adding the effect of an I Ks blocker on an already-compromised I Kr has been shown to additionally decrease the repolarization reserve, potentiating the action potential-prolonging effect of the I Kr blocker. 16 These concentrations are well within the therapeutically relevant range. In one study of 8 patients with relapsed APL, mean peak plasma arsenic concentration was 6.85 mol/L (range, 5.54 to 7.30 mol/L), and after 10 hours, it was 1 mol/L. 2 Unexpectedly, our data also showed that exposure of HERG-or KCNQ1ϩKCNE1-transfected CHO cells to As 2 O 3 activates a time-independent outward current. This I K-ATP -like current was also activated to a similar extent in GFPtransfected CHO cells exposed to As 2 O 3 and could be reversed by adding glibenclamide 10 mol/L, an I K-ATP blocker. 17 Indeed, the effects of As 2 O 3 in GFP-transfected CHO cells were comparable to those of the I K-ATP activator pinacidil. 17 Interestingly, one of the most common non-lifethreatening side effects of As 2 O 3 is hyperglycemia, observed in up to 45% of patients. 4 This effect has also been associated with other I K-ATP activators, such as diazoxide. 17 Moreover, depletion of intracellular ATP, as seen for example during cardiac ischemia, has been shown to activate I K-ATP . 17 Interestingly, arsenic is also recognized to uncouple cardiac mitochondrial oxidative phosphorylation. 18 The mechanism is thought to be related to competitive substitution of arsenic for inorganic phosphate in the formation of ATP. 18 As a result, arsenic-induced reduction of cardiac phosphorylation likely causes depletion of intracellular ATP and thus activation of cardiac I K-ATP .
Therefore, while blocking both I Kr and I Ks at therapeutic concentrations, thereby producing a severe lesion in repolarization reserve, As 2 O 3 also activates I K-ATP , which may partially restore repolarization reserve and thus contribute to variability in the extent of QT-interval prolongation and onset of ventricular arrhythmias during arsenic therapy.
Conclusions
As 2 O 3 is a potent blocker of both I Kr and I Ks . On the other hand, it also activates cardiac I K-ATP , which may blunt QT prolongation and arrhythmia risk by restoring repolarization reserve. The risk of torsades de pointes can be reduced by adherence to guidelines for safe use of the drug. In addition, variability in the extent of QT effects among patients may reflect this unusual combination of potassium channel actions.
